Please enable JavaScript to continue using this application.

Compare $IMRX vs $UPB | Chartloom

Compare

$IMRX vs $UPB

Immuneering Corp · Upstream Bio Inc

IMRX

Immuneering Corp

UPB

Upstream Bio Inc

Compare $IMRX vs $UPB

Comparing Immuneering Corp and Upstream Bio Inc

IMRXImmuneering Corp

UPBUpstream Bio Inc

IMRXImmuneering Corp

Market cap

$255M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.5%

52W performance

-39.4%

FCF yield

-22.4%

UPBUpstream Bio Inc

Market cap

$256M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

168.72x

Rev growth (TTM)

16.0%

YTD performance

-82.6%

52W performance

-75.2%

FCF yield

-53.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMRX

UPB

Detailed metrics comparison

IMRX

Immuneering Corp

UPB

Upstream Bio Inc

Market Cap

IMRX$255M

UPB$256M

Enterprise Value

IMRX$214M

UPB$176M

Price

IMRX$3.94

UPB$4.70

P/E Ratio

IMRXN/A

UPBN/A

P/S Ratio

IMRX526.64x

UPB80.99x

EV/Sales

IMRX443.99x

UPB55.85x

EV/EBITDA

IMRX0.00x

UPB0.00x

P/B Ratio

IMRX1.38x

UPB1.02x

P/FCF Ratio

IMRXN/A

UPBN/A

EV/FCF

IMRX-3.75x

UPB-1.29x

PEG Ratio

IMRXN/A

UPBN/A

Forward P/E (NTM)

IMRXN/A

UPBN/A

Forward P/S (NTM)

IMRXN/A

UPB168.72x

Revenue (TTM)

IMRX$0

UPB$3M

Revenue Growth (YoY)

IMRXN/A

UPB16.0%

Forward Rev Growth

IMRX100.5%

UPB-48.7%

Gross Margin (TTM)

IMRX28.0%

UPB0.0%

Operating Margin (TTM)

IMRX0.0%

UPB0.0%

EBITDA Margin (TTM)

IMRX0.0%

UPB-5376.3%

Net Margin (TTM)

IMRX0.0%

UPB-4955.7%

FCF Margin (TTM)

IMRXN/A

UPB-4321.2%

Net Income (TTM)

IMRX$-57M

UPB$-157M

FCF (TTM)

IMRX$-57M

UPB$-136M

EPS (TTM)

IMRX-$0.89

UPB-$2.87

ROE (TTM)

IMRX-2715.0%

UPB-4840.0%

ROA (TTM)

IMRX-2574.0%

UPB-4657.0%

ROIC (TTM)

IMRX-2715.0%

UPB-4840.0%

Cash

IMRX$41M

UPB$79M

Debt

IMRX$0

UPB$0

Net Cash/Debt

IMRX$41M

UPB$79M

Current Ratio (TTM)

IMRX19.47x

UPB27.99x

Quick Ratio (TTM)

IMRX18.47x

UPB27.84x

Debt/Equity (TTM)

IMRX0.00x

UPB0.00x

Debt/Assets (TTM)

IMRX0.0%

UPB0.0%

Interest Coverage (TTM)

IMRXN/A

UPBN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

UPB0.00x

Beta

IMRX0.34

UPB2.30

52W Performance

IMRX-39.4%

UPB-75.2%

YTD Performance

IMRX-40.5%

UPB-82.6%

% from 52W High

IMRX-53.5%

UPB-86.0%

% from 52W Low

IMRX9.4%

UPB7.7%

Asset Turnover (TTM)

IMRX0.00x

UPB0.01x

FCF Yield (TTM)

IMRX-22.4%

UPB-53.4%

Earnings Yield (TTM)

IMRX-22.5%

UPB-61.2%

Dividend Yield (TTM)

IMRXN/A

UPBN/A

Rule of 40

IMRX0.0

UPB-4,305.2

EV/GP/RG

IMRXN/A

UPBN/A

Ticker research

View IMRX research View UPB research

Metric	IMRX Immuneering Corp	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$255M	$256M
Enterprise Value	$214M	$176M
Price	$3.94	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	526.64x	80.99x
EV/Sales	443.99x	55.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	168.72x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	100.5%	-48.7%
Profitability
Gross Margin (TTM)	28.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5376.3%
Net Margin (TTM)	0.0%	-4955.7%
FCF Margin (TTM)	N/A	-4321.2%
Net Income (TTM)	$-57M	$-157M
FCF (TTM)	$-57M	$-136M
EPS (TTM)	-$0.89	-$2.87
ROE (TTM)	-2715.0%	-4840.0%
ROA (TTM)	-2574.0%	-4657.0%
ROIC (TTM)	-2715.0%	-4840.0%
Financial Health
Cash	$41M	$79M
Debt	$0	$0
Net Cash/Debt	$41M	$79M
Current Ratio (TTM)	19.47x	27.99x
Quick Ratio (TTM)	18.47x	27.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	2.30
52W Performance	-39.4%	-75.2%
YTD Performance	-40.5%	-82.6%
% from 52W High	-53.5%	-86.0%
% from 52W Low	9.4%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-22.4%	-53.4%
Earnings Yield (TTM)	-22.5%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,305.2
EV/GP/RG	N/A	N/A
Ticker research	View IMRX research	View UPB research

Valuation

P/S Ratio

UPB

80.99x

IMRX

526.64x

EV/FCF

IMRX

-3.75x

UPB

-1.29x

Growth & revenue

Revenue Growth TTM

UPB

16.0%

Forward Revenue Growth

IMRX

100.5%

UPB

-48.7%

Profitability & performance

Gross Margin

IMRX

28.0%

UPB

0.0%

ROE

IMRX

-2715.0%

UPB

-4840.0%

FCF Yield %

IMRX

-22.4%

UPB

-53.4%

52-Week Performance

IMRX

-39.4%

UPB

-75.2%

Detailed metrics comparison

IMRX

Immuneering Corp

UPB

Upstream Bio Inc

Market Cap

IMRX$255M

UPB$256M

Enterprise Value

IMRX$214M

UPB$176M

Price

IMRX$3.94

UPB$4.70

P/E Ratio

IMRXN/A

UPBN/A

P/S Ratio

IMRX526.64x

UPB80.99x

EV/Sales

IMRX443.99x

UPB55.85x

EV/EBITDA

IMRX0.00x

UPB0.00x

P/B Ratio

IMRX1.38x

UPB1.02x

P/FCF Ratio

IMRXN/A

UPBN/A

EV/FCF

IMRX-3.75x

UPB-1.29x

PEG Ratio

IMRXN/A

UPBN/A

Forward P/E (NTM)

IMRXN/A

UPBN/A

Forward P/S (NTM)

IMRXN/A

UPB168.72x

Revenue (TTM)

IMRX$0

UPB$3M

Revenue Growth (YoY)

IMRXN/A

UPB16.0%

Forward Rev Growth

IMRX100.5%

UPB-48.7%

Gross Margin (TTM)

IMRX28.0%

UPB0.0%

Operating Margin (TTM)

IMRX0.0%

UPB0.0%

EBITDA Margin (TTM)

IMRX0.0%

UPB-5376.3%

Net Margin (TTM)

IMRX0.0%

UPB-4955.7%

FCF Margin (TTM)

IMRXN/A

UPB-4321.2%

Net Income (TTM)

IMRX$-57M

UPB$-157M

FCF (TTM)

IMRX$-57M

UPB$-136M

EPS (TTM)

IMRX-$0.89

UPB-$2.87

ROE (TTM)

IMRX-2715.0%

UPB-4840.0%

ROA (TTM)

IMRX-2574.0%

UPB-4657.0%

ROIC (TTM)

IMRX-2715.0%

UPB-4840.0%

Cash

IMRX$41M

UPB$79M

Debt

IMRX$0

UPB$0

Net Cash/Debt

IMRX$41M

UPB$79M

Current Ratio (TTM)

IMRX19.47x

UPB27.99x

Quick Ratio (TTM)

IMRX18.47x

UPB27.84x

Debt/Equity (TTM)

IMRX0.00x

UPB0.00x

Debt/Assets (TTM)

IMRX0.0%

UPB0.0%

Interest Coverage (TTM)

IMRXN/A

UPBN/A

Net Debt/EBITDA (TTM)

IMRX0.00x

UPB0.00x

Beta

IMRX0.34

UPB2.30

52W Performance

IMRX-39.4%

UPB-75.2%

YTD Performance

IMRX-40.5%

UPB-82.6%

% from 52W High

IMRX-53.5%

UPB-86.0%

% from 52W Low

IMRX9.4%

UPB7.7%

Asset Turnover (TTM)

IMRX0.00x

UPB0.01x

FCF Yield (TTM)

IMRX-22.4%

UPB-53.4%

Earnings Yield (TTM)

IMRX-22.5%

UPB-61.2%

Dividend Yield (TTM)

IMRXN/A

UPBN/A

Rule of 40

IMRX0.0

UPB-4,305.2

EV/GP/RG

IMRXN/A

UPBN/A

Ticker research

View IMRX research View UPB research

Metric	IMRX Immuneering Corp	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$255M	$256M
Enterprise Value	$214M	$176M
Price	$3.94	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	526.64x	80.99x
EV/Sales	443.99x	55.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.38x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	168.72x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	100.5%	-48.7%
Profitability
Gross Margin (TTM)	28.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5376.3%
Net Margin (TTM)	0.0%	-4955.7%
FCF Margin (TTM)	N/A	-4321.2%
Net Income (TTM)	$-57M	$-157M
FCF (TTM)	$-57M	$-136M
EPS (TTM)	-$0.89	-$2.87
ROE (TTM)	-2715.0%	-4840.0%
ROA (TTM)	-2574.0%	-4657.0%
ROIC (TTM)	-2715.0%	-4840.0%
Financial Health
Cash	$41M	$79M
Debt	$0	$0
Net Cash/Debt	$41M	$79M
Current Ratio (TTM)	19.47x	27.99x
Quick Ratio (TTM)	18.47x	27.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	2.30
52W Performance	-39.4%	-75.2%
YTD Performance	-40.5%	-82.6%
% from 52W High	-53.5%	-86.0%
% from 52W Low	9.4%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-22.4%	-53.4%
Earnings Yield (TTM)	-22.5%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,305.2
EV/GP/RG	N/A	N/A
Ticker research	View IMRX research	View UPB research